0001562180-22-003666.txt : 20220503 0001562180-22-003666.hdr.sgml : 20220503 20220503161448 ACCESSION NUMBER: 0001562180-22-003666 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220501 FILED AS OF DATE: 20220503 DATE AS OF CHANGE: 20220503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Derakhshan Behrad CENTRAL INDEX KEY: 0001853109 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40236 FILM NUMBER: 22887023 MAIL ADDRESS: STREET 1: 3415 COLORADO AVE. CITY: BOULDER STATE: CO ZIP: 80303 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc. CENTRAL INDEX KEY: 0001710072 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821725586 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3415 COLORADO AVE. CITY: BOULDER STATE: CO ZIP: 80303 BUSINESS PHONE: 303-735-8373 MAIL ADDRESS: STREET 1: 3415 COLORADO AVE. CITY: BOULDER STATE: CO ZIP: 80303 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-05-01 false 0001710072 Edgewise Therapeutics, Inc. EWTX 0001853109 Derakhshan Behrad C/O EDGEWISE THERAPEUTICS, INC. 3145 COLORADO AVE. BOULDER CO 80303 false true false false Chief Business Officer Restricted Stock Units 0.00 2022-05-01 4 A false 15625.00 0.00 A 2025-05-01 Common Stock 15625.00 15625.00 D RSUs granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in three equal annual installments beginning on May 1, 2023. /s/ John R Moore Attorney-in-Fact for Behrad Derakhshan 2022-05-03